Loading...
Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) was the first malignancy for which immunotherapy, in the form of allogeneic hematopoietic stem cell transplantation (allo-HSCT), was integrated into the standard of care. Allo-HSCT however is an imperfect therapy associated with significant morbidity and mortality while...
Na minha lista:
| Udgivet i: | Curr Drug Targets |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6321986/ https://ncbi.nlm.nih.gov/pubmed/25706110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1389450116666150223120005 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|